(Q52706260)

6 May 2018

title

Antiarrhythmic drugs: clinical pharmacology and therapeutic uses. (English)

1 reference

6 May 2018

1 reference

J L Anderson

1

1 reference

6 May 2018

D C Harrison

series ordinal

2

1 reference

6 May 2018

P J Meffin

series ordinal

3

1 reference

6 May 2018

R A Winkle

series ordinal

4

1 reference

6 May 2018

publication date

1 April 1978

1 reference

6 May 2018

published in

Drugs

1 reference

6 May 2018

volume

15

1 reference

6 May 2018

issue

4

1 reference

6 May 2018

page(s)

271-309

1 reference

6 May 2018

https://scigraph.springernature.com/pub.10.2165/00003495-197815040-00003

exact match

0 references

cites work

Response optimization of drug dosage: antiarrhythmic studies with tocainide

1 reference

12 December 2020

Pharmacokinetic approach to the clinical use of lidocaine intravenously.

1 reference

12 December 2020

Clinical applications of the pharmacokinetics of lidocaine

1 reference

12 December 2020

Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs

1 reference

12 December 2020

The convulsant potency of lidocaine and its N-dealkylated metabolites

1 reference

12 December 2020

Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding

1 reference

12 December 2020

Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil

1 reference

12 December 2020

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

1 reference

12 December 2020

1 reference

12 December 2020

Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial Infarction

1 reference

12 December 2020

Phenytoin after recovery from myocardial infarction. Controlled trial in 568 patients

1 reference

12 December 2020

1 reference

12 December 2020

Acebutolol metabolite plasma concentration during chronic oral therapy

1 reference

12 December 2020

Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction

1 reference

12 December 2020

SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT

1 reference

12 December 2020

Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography

1 reference

12 December 2020

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

1 reference

12 December 2020

Hemodynamic effects of intravenously administered quinidine on the transplanted human heart

1 reference

12 December 2020

Quinidine Elimination in Patients with Congestive Heart Failure or Poor Renal Function

1 reference

12 December 2020

Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method

1 reference

12 December 2020

Bretylium Tosylate for Suppression of Ventricular Fibrillation after Experimental Myocardial Infarction

1 reference

12 December 2020

Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. B

1 reference

12 December 2020

Effect of amiodarone in the Wolff-Parkinson-White syndrome

1 reference

12 December 2020

Serum Procainamide Levels As Therapeutic Guides

1 reference

12 December 2020

Acute oral testing for determining antiarrhythmic drug efficacy. I. Quinidine

1 reference

12 December 2020

Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials.

1 reference

12 December 2020

Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration

1 reference

12 December 2020

Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm

1 reference

12 December 2020

Some Causes of Ineffectiveness of Diphenylhydantoin

1 reference

12 December 2020

The electrophysiologic effects of quinidine in the transplanted human heart

1 reference

12 December 2020

The current status of diphenylhydantoin in heart disease

1 reference

12 December 2020

Treatment of chronic ventricular dysrhythmias with a new drug: aprindine (AC 1802)

1 reference

12 December 2020

Absorption, half-life, and toxicity of oral aprindine in patients with acute myocardial infarction

1 reference

12 December 2020

Neural and psychologic mechanisms and the problem of sudden cardiac death

1 reference

12 December 2020

Experience with bretylium tosylate by a hospital cardiac arrest team

1 reference

12 December 2020

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

1 reference

12 December 2020

Interaction of Quinidine with Anticonvulsant Drugs

1 reference

12 December 2020

Effectiveness of Bretylium Tosylate against Refractory Ventricular Arrhythmias

1 reference

12 December 2020

Role of concentration-dependent plasma protein binding in disopyramide disposition

1 reference

12 December 2020

Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function

1 reference

12 December 2020

Physiological disposition of verapamil in man

1 reference

12 December 2020

Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

1 reference

12 December 2020

N‐acetylprocainamide levels in patients with end‐stage renal failure

1 reference

12 December 2020

General aspects of anti-arrhythmic treatment with aprindine

1 reference

12 December 2020

Procainamide dosage schedules, plasma concentrations, and clinical effects

1 reference

12 December 2020

Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones

1 reference

12 December 2020

Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate

1 reference

12 December 2020

Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation

1 reference

12 December 2020

EFFECTS OF BETA-ADRENERGIC BLOCKADE WITH PROPRANOLOL IN PATIENTS WITH ATRIAL ARRHYTHMIAS

1 reference

12 December 2020

Factors influencing infarct size following experimental coronary artery occlusions

1 reference

12 December 2020

??-Adrenoceptor Blocking Drugs and Acute Myocardial Infarction1

1 reference

12 December 2020

The pharmacokinetics of procainamide in normal subjects using a specific gas chromatographic assay

1 reference

12 December 2020

Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man

1 reference

12 December 2020

Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in man.

1 reference

12 December 2020

Successful treatment by overdrive pacing of recurrent quinidine syncope due to ventricular tachycardia

1 reference

12 December 2020

N-acetylprocainamide: an active metabolite of procainamide

1 reference

12 December 2020

Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias

1 reference

12 December 2020

Quinidine syncope and the delayed repolarization syndromes

1 reference

12 December 2020

Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction

1 reference

12 December 2020

Propranolol treatment of chronic intractable supraventricular arrhythmias

1 reference

12 December 2020

Quinidine-induced ventricular flutter and fibrillation without digitalis therapy

1 reference

12 December 2020

Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study.

1 reference

12 December 2020

Hemodynamic effects of procainamide in patients with acute myocardial infarction and comparison with lidocaine.

1 reference

12 December 2020

Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans

1 reference

12 December 2020

Biochemical and genetic factors regulating dilantin metabolism in man.

1 reference

12 December 2020

Metabolism of procainamide in normal and cardiac subjects

1 reference

12 December 2020

Treatment of ventricular arrhythmias with mexiletine (Kö 1173).

1 reference

12 December 2020

Pharmacokinetics in man of theN-acetylated metabolite of proeainamide

1 reference

12 December 2020

Cardiac and peripheral vascular effects of diphenylhydantoin sodium

1 reference

12 December 2020

Disopyramide phosphate: Clinical efficacy of a new oral antiarrhythmie drug

1 reference

12 December 2020

Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart Disease

1 reference

12 December 2020

Mexiletine (Kö 1173) in the management of ventricular dysrhythmias

1 reference

12 December 2020

Suppression of premature ventricular contractions by acebutolol

1 reference

12 December 2020

Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants

1 reference

12 December 2020

Investigations of the mode of action of a new antidysrhythmic drug, Kö 1173

1 reference

12 December 2020

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

1 reference

12 December 2020

Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion

1 reference

12 December 2020

Antiarrhythmic potency of N-acetylprocainamide

1 reference

12 December 2020

Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin

1 reference

12 December 2020

Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions

1 reference

12 December 2020

Dangerous consequence from use of phenytoin in atrial flutter

1 reference

12 December 2020

Control of recurrent supraventricular tachycardia with amiodarone hydrochloride

1 reference

12 December 2020

Sinus recovery time after disopyramide phosphate

1 reference

12 December 2020

Evaluation of propranolol and quinidine in the treatment of quinidine-resistant arrhythmias

1 reference

12 December 2020

Disopyramide: serum level and arrhythmia conversion

1 reference

12 December 2020

Agranulocytosis and aprindine

1 reference

12 December 2020

Quinidine syncope. A report of successful treatment with bretylium tosylate

1 reference

12 December 2020

Influence of acute viral hepatitis on phenytoin kinetics and protein binding

1 reference

12 December 2020

1 reference

12 December 2020

Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure

1 reference

12 December 2020

Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans

1 reference

12 December 2020

Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgery

1 reference

12 December 2020

Treatment of recurrent symptomatic ventricular tachycardia

1 reference

12 December 2020

Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs

1 reference

12 December 2020

Trial of propranolol in acute myocardial infarction.

1 reference

12 December 2020

Pharmacokinetics in patients with cardiac failure

1 reference

12 December 2020

Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man

1 reference

12 December 2020

Kinetics of the oral antiarrhythmie lidocaine congener, tocainide

1 reference

12 December 2020

Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution

1 reference

12 December 2020

Metabolic disposition of diphenylhydantoin in normal human subiects following intravenous administration

1 reference

12 December 2020

Pharmacokinetics of propranolol in normal healthy volunteers

1 reference

12 December 2020

DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE

1 reference

12 December 2020

Observations on patients with primary ventricular fibrillation complicating acute myocardial infarction

1 reference

12 December 2020

Electrophysiological evaluation of disopyramide in man

1 reference

12 December 2020

Individualization of propranolol therapy.

1 reference

12 December 2020

Cardiac effects of disopyramide

1 reference

12 December 2020

Dose-ranging trial of N-acetylprocainamide in patients with premature ventricular contractions

1 reference

12 December 2020

Effects of long-term treatment with procaine amide. A prospective study with special regard to ANF and SLE in fast and slow acetylators

1 reference

12 December 2020

Procainamide and phenytoin. Comparative study of their antiarrhythmic effects at apparent therapeutic plasma levels

1 reference

12 December 2020

Phenytoin in post-operative cardiac arrhythmias

1 reference

12 December 2020

The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent

1 reference

12 December 2020

Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate

1 reference

12 December 2020

Pharmacokinetic studies of quinidine in patients with arrhythmias

1 reference

12 December 2020

Polymorphic acetylation of procainamide in man

1 reference

12 December 2020

Propranolol--ten years from introduction

1 reference

12 December 2020

The electrophysiological effects of intramuscular guinidine on the atrioventricular conducting system in man

1 reference

12 December 2020

Quinidine for prophylaxis of arrhythmias in acute myocardial infarction

1 reference

12 December 2020

Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study

1 reference

12 December 2020

Efficacy of Disopyramide Phosphate in the Treatment of Refractory Ventricular Tachycardia

1 reference

12 December 2020

Clinical pharmacokinetics of digitoxin

1 reference

12 December 2020

Long-term oral antiarrhythmic therapy with aprindine (AC 1802)

1 reference

12 December 2020

Therapeutic effectivenss and plasma levels of aprindine, a new antidysrhythmic drug

1 reference

12 December 2020

Diphenylhydantoin in the Prevention of Recurring Ventricular Tachycardia

1 reference

12 December 2020

Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300 mg intramuscular injection. A double-blind, randomized study of 300 hospitalized patients with acute myocardial infarction

1 reference

12 December 2020

Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment

1 reference

12 December 2020

Clinical efficacy of amiodarone as an antiarrhythmic agent

1 reference

12 December 2020

Aprindine (AC 1802), a new anti-arrhythmic drug.

1 reference

12 December 2020

Clinical Pharmacokinetics of Digoxin

1 reference

12 December 2020

Pharmacokinetics of procainamide intravenously and orally as conventional and slow-release tablets

1 reference

12 December 2020

Quinidine Excretion in Aciduria and Alkaluria

1 reference

12 December 2020

Procainamide-induced lupus erythematosus. Clinical and laboratory observations

1 reference

12 December 2020

The effects of urine pH and plasma protein binding on the renal clearance of disopyramide

1 reference

12 December 2020

Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.

1 reference

12 December 2020

Disposition kinetics of quinidine

1 reference

12 December 2020

Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results

1 reference

12 December 2020

Verapamil in the treatment of paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Verapamil in cardiac arrhythmias

1 reference

12 December 2020

Clinical Pharmacokinetics of β-Adrenoreceptor Blocking Drugs

1 reference

12 December 2020

Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic Effects

1 reference

12 December 2020

Electrophysiology and pharmacology of cardiac arrhythmias. VIII. Cardiac effects of diphenylhydantoin. B

1 reference

12 December 2020

Diphenylhydantoin as an Antiarrhythmic Drug

1 reference

12 December 2020

Bretylium tosylate in prevention of cardiac dysrhythmias after myocardial infarction

1 reference

12 December 2020

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.

1 reference

12 December 2020

Clinical pharmacological studies of Kö 1173--a new antiarrhythmic agent.

1 reference

12 December 2020

Pharmacokinetics of lidocaine in man

1 reference

12 December 2020

Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metabolite

1 reference

12 December 2020

Electrophysiological effects of mexiletine in man.

1 reference

12 December 2020

Protein Binding and Kinetics of Drugs in Liver Diseases

1 reference

12 December 2020

Comparative effectiveness of exercise testing and continuous monitoring for detecting arrhythmias in patients with previous myocardial infarction

1 reference

12 December 2020

Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites

1 reference

12 December 2020

Propranolol disposition in chronic liver disease: a physiological approach

1 reference

12 December 2020

Interactions with Antiepileptic Drugs

1 reference

12 December 2020

The present status of therapy of the cardiac arrhythmias with quinidine

1 reference

12 December 2020

INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY

1 reference

12 December 2020

Letter: Reduction of sudden Deaths after myocardial infarction

1 reference

12 December 2020

Individualization of phenytoin dosage regimens

1 reference

12 December 2020

Electrophysiological effects of aprindine on isolated heart preparations.

1 reference

12 December 2020

Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction

1 reference

12 December 2020

Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.

1 reference

12 December 2020

Evaluation of bretylium tosylate for the treatment of premature ventricular contractions

1 reference

12 December 2020

Verapamil blockade of slow Na+ and Ca++ responses in myocardial cells

1 reference

12 December 2020

The effects of lidocaine on the canine ECG and electrophysiologic properties of Purkinje fibers

1 reference

12 December 2020

Quinidine toxicity and its treatment. An Experimental study

1 reference

12 December 2020

Effect of a Digitalis Drug on Ventricular Premature Beats

1 reference

12 December 2020

Effect of propranolol on mortality in patients with angina

1 reference

12 December 2020

Verapamil: a review of its pharmacological properties and therapeutic use.

1 reference

12 December 2020

Comparative plasma concentrations of quinidine following administration of one intramuscular and three oral formulations to 13 human subjects

1 reference

12 December 2020

Interactions of Antiepileptic Drugs

1 reference

12 December 2020

Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic Beats

1 reference

12 December 2020

Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.

1 reference

12 December 2020

Pharmacologic therapy of ventricular arrhythmias

1 reference

12 December 2020

Model for exchange kinetics of aprindine in man after single and multiple doses

1 reference

12 December 2020

Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose

1 reference

12 December 2020

Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

1 reference

12 December 2020

Effects of lidocaine on refractory periods in man.

1 reference

12 December 2020

Disease and Acetylation Polymorphism

1 reference

12 December 2020

The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972

1 reference

12 December 2020

Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green

1 reference

12 December 2020

The Use of procaine amide and lidocaine in the treatment of cardiac arrhythmias

1 reference

12 December 2020

Long-term treatment of ventricular arrhythmias with oral mexiletine

1 reference

12 December 2020

Treatment of recurrent ventricular tachycardia and fibrillation with aprindine

1 reference

12 December 2020

Ambulatory Electrocardiography for Diagnosis and Treatment of Cardiac Arrhythmias

1 reference

12 December 2020

Beta-adrenergic receptor blocking drugs in cardiac arrhythmias

1 reference

12 December 2020

Intracardiac Electrocardiography in the Analysis and Understanding of Cardiac Arrhythmias

1 reference

12 December 2020

10.2165/00003495-197815040-00003

Identifiers

DOI

1 reference

6 May 2018

Dimensions Publication ID

1013893976

0 references

Fatcat ID

release_rh6j2oji2bdojoe3hvvfsiuwmy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rh6j2oji2bdojoe3hvvfsiuwmy

24 November 2022

mapped directly with Wikidata item

1 reference

6 May 2018